Cerebrotendinous Xanthomatosis (CTX) Prevalence Study

NCT02638220 · clinicaltrials.gov ↗
COMPLETED
Status
442
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Travere Therapeutics, Inc.